GlassScriptPhysician profile
Alice A Lin
NPI 1336276427
$1,248.99
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $509 · 2020: $120 · 2021: $378 · 2022: $242.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $520.92 | 2019-2022 | |
| Glaukos Corporation | $263.49 | 2019-2021 | |
| Allergan, INC. | $132.06 | 2019 | |
| Coopervision INC. | $114.81 | 2021 | |
| Ocular Therapeutix, INC. | $88.80 | 2019 | |
| Novartis Pharmaceuticals Corporation | $37.63 | 2020-2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $28.83 | 2019-2021 | |
| Aerie Pharmaceuticals, INC. | $26.55 | 2019-2021 | |
| Eyepoint US, INC. | $18.85 | 2019 | |
| Carl Zeiss Meditec, INC. | $17.05 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alice Lin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.